Physician profile
Susan Watson
NPI 1184685646
$7,151.76
in general payments reported to CMS, 2019-2025
18 companies · $1,231 in 2025
The $1,231 reported for 2025 was more than what 82% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $62.51 · 2021: $147 · 2022: $458 · 2023: $1,469 · 2024: $3,385 · 2025: $1,231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,408 · Consulting Fee: $1,500 · Travel and Lodging: $802 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,407.80 |
| Consulting Fee | $1,500.00 |
| Travel and Lodging | $802.46 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $375.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $2,660.60 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $1,352.81 | 2019-2025 | |
| Bausch & Lomb Americas INC. | $680.53 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Oyster Point Pharma, INC. | $613.60 | 2022-2024 | Tyrvaya |
| Harrow Eye, LLC | $551.88 | 2024-2025 | Vevye, Ilevro |
| Dompe US, INC. | $230.88 | 2021-2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $175.17 | 2021-2025 | Lipiview Ocular Surface Interferometer, Lipiflow System Activator (Disposable) |
| Mallinckrodt Hospital Products INC. | $154.25 | 2024 | Acthar |
| Sun Pharmaceutical Industries INC. | $149.89 | 2019-2025 | |
| Rxsight INC | $146.97 | 2022 | |
| Allergan, INC. | $141.69 | 2019-2021 | |
| Alcon Vision LLC | $125.39 | 2023-2025 | Rocklatan, Eysuvis |
| Eyevance Pharmaceuticals LLC | $55.96 | 2019-2022 | |
| Mallinckrodt Enterprises LLC | $32.21 | 2019 | |
| Thea Pharma INC. | $22.75 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Quidel Corporation | $19.70 | 2019 | |
| Carl Zeiss Meditec, INC. | $19.13 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.